Skip to main content
SpringerLink
Log in

Relationship of Pharmacokinetically-Calculated Volumes of Distribution to the Physiologic Distribution of Liposomal Drugs in Tissues: Implications for the Characterization of Liposomal Formulations

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. D. Lasic. Novel applications of liposomes. Trends Biotechnol. 16:307-321 (1998).

    Google Scholar 

  2. D. Papahadjopoulos. Fate of liposomes in vivo: a brief introductory review. J. Liposome Res. 6:3-17 (1996).

    Google Scholar 

  3. Physicians Desk Reference, 54th edition, Medical Economics Co., Mountvale, NJ, 2000 pp. 509, 1090, 3341, 1654.

  4. M. Rowland and T. N. Tozer. Clinical Pharmacokinetics Concepts and Applications. Third edition. Williams & Wilkins, Baltimore, 1995.

    Google Scholar 

  5. T. J. Walsh, V. Yeldandi, M. McEvoy, C. Gonzalez, S. Chanock, A. Freifeld, N. I. Seibel, P. O. Whitcomb, P. Jarosinski, G. Boswell, I. Bekersky, A. Alak, D. Buell, J. Barret, and W. Wilson. Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients. Antimicrob. Agents Chemother. 42:2391-2398 (1998).

    Google Scholar 

  6. A. Adedoyin, C. E. Swenson, L. E. Bolcsak, A. Hellmann, D. Radowska, G. Horwith, A. S. Janoff, and R. A. Branch. A pharmacokinetic study of amphotericin B lipid complex injection (Abelcet) in patients with definite or probable systemic fungal infections. Antimicrob. Agents. Chemother. 44:2900-2902 (2000).

    Google Scholar 

  7. The Liposome Company, Inc. Abelcet, amphotericin B lipid complex injection. In Physicians Desk Reference, 54th edition, Medical Economics Co., Mountvale, NJ, 2000 pp. 1653-1655.

    Google Scholar 

  8. O. Ringden, F. Meunire, J. Tollemar, P. Ricci, S. Tura, E. Kuse, M. A. Viviani, N. C. Gorin, J. Klastersky, P. Fenaux, H. G. Prentice, and G. Ksionski. Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. J. Antimicrob. Chemother. 28(Suppl. B):73-82 (1991).

    Google Scholar 

  9. G. W. Boswell, I. Bekersky, D. Buell, R. Hiles, and T. J. Walsh. Toxicological profile and pharmacokinetics of a unilamellar liposomal vesicle formulation of amphotericin B in rats. Antimicrob. Agents Chemother. 42:263-268 (1998).

    Google Scholar 

  10. I. Bekersky, G. W. Boswell, R. Hiles, R. M. Fielding, D. Buell, and T. J. Walsh. Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal amphotericin B (AmBisome): A 91-day study in rats. Pharm Res. 17:1494-1502 (2000).

    Google Scholar 

  11. I. Bekersky, G. W. Boswell, R. Hiles, R. M. Fielding, D. Buell, and T. J. Walsh. Safety and toxicokinetics of intravenous liposomal amphotericin B (AmBisome) in beagle dogs. Pharm. Res. 16:1694-1701 (1999).

    Google Scholar 

  12. R. M. Fielding, R. O. Lewis, and L. Moon-McDermott. Altered tissue distribution and elimination of amikacin encapsulated in unilamellar, low-clearance liposomes (MiKasome). Pharm. Res. 15:1775-1781 (1998).

    Google Scholar 

  13. C. W. Chang, L. Barber, C. Ouyang, M. B. Bally, and T. D. Madden. Plasma clearance, biodistribution and therapeutic properties of mitoxantrone encapsulated in conventional and sterically stabilized liposomes after intravenous administration in BDF1 mice. Br. J. Cancer 75:169-177 (1997).

    Google Scholar 

  14. M. S. Newman, G. T. Colbern, P. K. Working, C. Engbers, and M. A. Amantea. Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice. Cancer Chemother. Pharmacol. 43:1-7 (1999).

    Google Scholar 

  15. E. A. Forssen, D. M. Coulter, and R. T. Proffitt. Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors. Cancer. Res. 53:3255-3261 (1992).

    Google Scholar 

  16. R. M. Schiffelers, I. A. J. M. Bakker-Woudenberg, S. V. Snijders, and G. Storm. Localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue: influence of liposome characteristics. Biochim. Biophys. Acta 1421:329-339 (1999).

    Google Scholar 

  17. A. H. Groll, D. Mickiene, K. Werner, R. Petraitiene, V. Petraitis, M. Calendario, A. Field-Ridley, J. Crisp, S. C. Piscatelli, and T. J. Walsh. Compartmental pharmacokinetics and tissue distribution of multilamellar liposomal nystatin in rabbits. Antimicrob. Agents. Chemother. 44:950-957 (2000).

    Google Scholar 

  18. B. Davies and T. Morris. Physiological Parameters in Laboratory Animals and Humans. Pharm. Res. 10:1093-1095 (1993).

    Google Scholar 

  19. M. Gibaldi, R. Nagashima, and G. Levy. Relationship between drug concentration in plasma or serum and amount of drug in the body. J. Pharm. Sci. 58:193-197 (1969).

    Google Scholar 

  20. H. Harashima and H. Kiwada. Liposomal targeting and drug delivery: Kinetic consideration. Adv. Drug Deliv. Rev. 19:425-444 (1996).

    Google Scholar 

  21. R. M. Fielding, L. Moon-McDermott, R. O. Lewis, and M. J. Horner. Pharmacokinetics and urinary excretion of amikacin in low-clearance unilamellar liposomes after single and repeated intravenous administration in the rhesus monkey. Antimicrob. Agents Chemother. 43:503-509 (1999).

    Google Scholar 

  22. P. Le Conte, F. Le Gallou, G. Potel, L. Struillon, D. Baron, and H. B. Drugeon. Pharmacokinetics, toxicity and efficacy of liposomal capreomycin in disseminated Mycobacterium avium beige mouse model. Antimicrob. Agents Chemother. 38:2695-2701 (1994).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Biologistic Services, 498 Skytrail Road, Boulder, Colorado, 80302-9462

    Robert M. Fielding

Authors
  1. Robert M. Fielding
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fielding, R.M. Relationship of Pharmacokinetically-Calculated Volumes of Distribution to the Physiologic Distribution of Liposomal Drugs in Tissues: Implications for the Characterization of Liposomal Formulations. Pharm Res 18, 238–242 (2001). https://doi.org/10.1023/A:1011096821662

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011096821662

Search

Navigation